Axios Re:Cap

Pfizer agrees to licensing deal for COVID-19 pill


Listen Later

Pfizer announced on Tuesday it will allow low and middle-income countries to make and distribute the company’s COVID-19 pill inexpensively. The move is an attempt to increase the global supply in 95 poorer nations.While the deal helps treat patients, the company has not made the same decision when it comes to its COVID-19 vaccine.

Axios Re:Cap host Felix Salmon is joined by Axios health care business reporter Bob Herman to discuss Pfizer’s decisions and the global ramifications.

...more
View all episodesView all episodes
Download on the App Store

Axios Re:CapBy Axios

  • 4.3
  • 4.3
  • 4.3
  • 4.3
  • 4.3

4.3

690 ratings


More shows like Axios Re:Cap

View all
WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,634 Listeners

WSJ What’s News by The Wall Street Journal

WSJ What’s News

4,326 Listeners

WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,744 Listeners

Marketplace by Marketplace

Marketplace

8,642 Listeners

Fareed Zakaria GPS by CNN

Fareed Zakaria GPS

3,452 Listeners

The Daily by The New York Times

The Daily

111,044 Listeners

Up First from NPR by NPR

Up First from NPR

55,842 Listeners

Radio Atlantic by The Atlantic

Radio Atlantic

2,239 Listeners

Post Reports by The Washington Post

Post Reports

5,412 Listeners

The Journal. by The Wall Street Journal & Gimlet

The Journal.

5,916 Listeners

Morning Brew Daily by Morning Brew

Morning Brew Daily

2,944 Listeners

1 big thing by Axios

1 big thing

2,021 Listeners

The Ezra Klein Show by New York Times Opinion

The Ezra Klein Show

15,326 Listeners

How It Happened by Axios

How It Happened

4,368 Listeners

The Big Take by Bloomberg

The Big Take

154 Listeners

The 7 by The Washington Post

The 7

1,145 Listeners

The Opinions by The New York Times Opinion

The Opinions

389 Listeners